This review of cannabinoids for neuropathic pain sleep examines a 2022 meta-analysis of eight randomized controlled trials involving 1,051 patients with chronic neuropathic pain. The findings showed statistically significant improvements in both sleep quality and pain intensity, alongside clinically important patient-reported improvements. The study also highlights important limitations, formulation variability, and safety considerations clinicians should discuss with patients considering cannabinoid therapy.